|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|
| Cash Flows from Operating Activities: | |
| Net income (loss) | |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |
| Interest earned on marketable securities held in Trust Account | |
| Unrealized gain on marketable securities held in Trust Account | |
| Changes in operating assets and liabilities: | |
| Prepaid expenses and other current assets | |
| Short-term prepaid insurance | |
| Accounts payable and accrued expenses | |
| Income taxes payable | |
| Net cash used in operating activities | |
| Cash Flows from Investing Activities: | |
| Investment of cash in Trust Account | |
| Cash withdrawn from Trust Account to pay income taxes | |
| Net cash used in investing activities | |
| Cash Flows from Financing Activities: | |
| Proceeds from sale of Units, net of underwriting discounts paid | |
| Proceeds from sale of private placement warrants | |
| Proceeds from promissory note - related party | |
| Repayment of promissory note - related party | |
| Payment of offering costs | |
| Net cash provided by (used in) financing activities | |
| Net Change in Cash | |
| Cash - Beginning of period | |
| Cash - End of period | |
| Supplemental cash flow information: | |
| Cash - End of period | |
| Non-Cash investing and financing activities: | |
| Offering costs included in accrued offering costs | |
| Accretion of Class A common stock to redemption value | |
| Deferred underwriting fee payable |
Loading...
